Menu

Orchestra BioMed Holdings, Inc. OBIO

Full chart Compare
Set alert

Price alert · OBIO

All alert types
5.68 USD +0.06 (+1.07%)

At closeNov 6, 2026, 4:27 PM EST

5.68 0.00 0.00%

After hours · Nov 6, 4:27 PM ET

5.14 Day range 6.04
3.49 52-week range 6.35
YTD
+36.87%
1 year
+49.08%

Revenue & Expenses

Other Income → Expenses: $254.00KExpenses → Selling, General & Admin: $26.91MExpenses → Research & Development: $58.19MExpenses → Interest Expense: $1.15MGross Profit → Expenses: $33.29MRevenue → Gross Profit: $33.29MRevenue → Cost of Revenue: $190.00KNet Loss → Expenses: $52.70MOther Income$254.00KGross Profit$33.29MNet Loss$52.70MCost of Revenue$190.00KExpenses$86.25MSelling, General & Admin$26.91MResearch & Development$58.19MInterest Expense$1.15MRevenue$33.48M

Latest period ending Dec 31, 2025 · select a line to chart its full history

OBIO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
33.48M2.64M2.76M3.53M-782.00K
33.29M2.43M2.57M3.32M-981.00K
-51.81M-64.30M-51.51M-32.66M-21.80M
-52.70M-61.02M-49.12M-33.61M-23.01M
-1.11-1.66-1.48-2.24-2.61
OBIO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
34.69M22.26M30.56M19.78M9.94M
114.86M76.17M95.21M95.57M13.53M
51.48M43.22M27.17M43.04M33.31M
32.44M16.53M1.69M11.87M5.67M
53.57M32.96M68.04M52.53M-19.78M
OBIO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-48.96M-50.56M-46.13M-29.29M-19.43M
-26.94M13.09M10.69M-64.12M13.02M
88.33M29.17M46.22M103.26M-3.99M
-489.00K-289.00K-78.00K-591.00K-274.00K
12.43M-8.30M10.78M9.85M-10.40M